Edition:
United Kingdom

Odonate Therapeutics Qtrly Loss Per Share $0.79


Monday, 30 Jul 2018 

July 30 (Reuters) - Odonate Therapeutics Inc ::ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018.ODONATE THERAPEUTICS INC - AS OF JUNE 30, 2018, ODONATE HAD $177.4 MILLION IN CASH.ODONATE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.79. 

Company Quote

32.35
 --
16 Aug 2019